Research ArticleLaboratory Studies
Pharmacokinetics of Iodine-123-IMBA for Melanoma Imaging
Ciaran Nicholl, Ashour Mohammed, William E. Hull, Bernd Bubeck and Michael Eisenhut
Journal of Nuclear Medicine January 1997, 38 (1) 127-133;
Ciaran Nicholl
Ashour Mohammed
William E. Hull
Bernd Bubeck


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Pharmacokinetics of Iodine-123-IMBA for Melanoma Imaging
Ciaran Nicholl, Ashour Mohammed, William E. Hull, Bernd Bubeck, Michael Eisenhut
Journal of Nuclear Medicine Jan 1997, 38 (1) 127-133;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
- Ultrasensitive detection of malignant melanoma using PET molecular imaging probes
- N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma
- Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma
- Melanin-Targeted Preclinical PET Imaging of Melanoma Metastasis
- [99mTcOAADT]-(CH2)2-NEt2: A Potential Small-Molecule Single-Photon Emission Computed Tomography Probe for Imaging Metastatic Melanoma